Want to join the conversation?
For FY16, $TMK expects net operating income from continuing operations per share to be $4.28-4.48. The midpoint of this 2016 guidance is $4.38, a $0.03 increase over previous guidance. The midpoint of the previous guidance would have been $4.35 excluding discontinued operations.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?